Hotel Information

Make your hotel reservations by Oct. 7 to receive the WSPA rate of $139/night. Mention you will be attending the WSPA meeting. The special rate applies Nov. 6-8. Visit the Tulalip Resort Casino and Spa.

Proposed Agenda

Faculty: Cristina DuVall, BA, BS, Pharm.D., WSU Clinical Research Associate/Geriatric Fellow, Family Home Care

ACPE # 130-000-08-076-L04 P&T

Friday November 7, 9:30-10:45 am | .150 CEU?s | Room: Chinook 2  

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Design a patient-specific pain management regimen including maintenance and breakthrough coverage.

·        Provide drug therapy modifications or recommendations using opioid conversions.

This presentation is a case-based approach to pain management strategies.

Chemical Dependency and the Pharmacy Profession, WRAPP-Washington Recovery Assistance Program for Pharmacy       

Faculty: Michaelene Kedzierski, R.Ph., CDP, Clinical Professor, Associate Director of Counseling Services, Office of academic and Student programs, School of Pharmacy, University of Washington and Consultant Pharmacist, Evergreen Treatment Services- Seattle (opioid addiction treatment)           

ACPE # 130-000-08-067-L05 P&T

Friday November 7, 11-12:15 pm | .150 CEU?s | Room: Chinook 1    

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Consider both legal and ethical responsibility with regard to reporting suspected drug diversion and suspected impairment

·        Develop a working awareness of the history, philosophy, and legal basis for the advocacy work of WRAPP in providing support and recovery assistance to pharmacy professionals whose ability to practice pharmacy with judgment, skill, competency and safety to the public may be impaired due to chemical dependence on alcohol or other drugs, emotional illness the aging process or loss of memory and motor skills.

·        Identify the role that they can personally play and the actions they will take to promote awareness of the recovery support services of WRAPP

The purpose of this presentation is to inform participants of the history, philosophy and working advocacy or WRAPP in providing support and recovery assistance to pharmacy professionals whose ability to practice pharmacy with judgment, skill, competency and safety to the public may be impaired due to chemical dependence on alcohol or other drugs, emotional illness, the aging process or loss of memory and motor skills.  Participants will develop an understanding of the impaired pharmacist rehabilitation rule and the WRAPP referral and monitoring process.  Through consideration of a case study, participants will examine their legal and ethical responsibilities with regard to reporting suspected drug diversion and suspected impairment and consider enabling behaviors in the workplace. Following completion of this presentation, participants will have adequate information to actively promote advocacy for pharmacy professionals in Washington State.

Pediatric Pharmacokinetics and Drug Dosing         

Faculty: Brenda Kelly, Pharm.D., Clinical Assistant Professor, Washington State University College of Pharmacy          

ACPE # 130-000-08-060-L01 P

Friday November 7, 11-12:15 pm | .150 CEU?s | Room: Chinook 2    

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Student Pharmacists At the completion of this program, the participant will be able to:

·        Describe the general differences in drug absorption, distribution, metabolism & elimination between preterm and term neonates, infants, children and adults.

·        Articulate examples of how the key pharmacokinetic differences between neonates, children and adults affect drug therapy.

·        Articulate inherent challenges in pharmacy care management of pediatric patients and modalities to combat these difficulties.

This program will discuss the key differences in pharmacokinetic parameters between preterm and term neonates, infants and adults and the impact of these differences and inherent challenges in managing drug therapy within this diverse patient population.

MTM 

Faculty: Jeff Rochon, Pharm.D., Director of Professional Development, Washington State Pharmacy Association, Steve Riddle, BS Pharm, BCPS, Lead Pharmacist , Harborview Medical Center Pharmacy Services, Medication Utilization & Quality Improvement, Assistant Clinical Professor, University Of Washington School of Pharmacy

ACPE #

Friday November 7, 1:30-2:45 pm | .150 CEU?s | Room: Chinook 1

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

HIV/AIDS Update for 2008-2009    

Faculty: Colleen Terriff, Pharm.D., BCPS-ID, AAHIVE, Clinical Associate Professor, WSU College of Pharmacy       

ACPE # 130-000-08-064-L01 P

Friday November 7, 1:30-2:45 pm | .150 CEU?s | Room: Chinook 2   

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Recognize when to start antiretroviral therapy, incorporating the latest guidelines

·        Select appropriate baseline and monitoring labs for HIV+ patient

·        Apply ambulatory care clinical pearls into pharmacotherapy recommendations

2008 was an exciting year for HIV medicine, with new pharmacotherapy genetic testing, potent antiretrovirals, and updated guidelines.  This interactive session will include case discussions of antiretroviral therapy, baseline and follow-up labs, plus useful clinical pearls, focusing on immunizations, side effect management and valuable resources.

Spanish Translation and Counseling Training Workshop 
Workshop handout 
Pearls handout
Faculty: Luis Ramos, Pharm.D. Candidate, University of Washington    
ACPE # 130-000-08-038-L04 P&T
Friday November 7, 3-4:15 pm | .150 CEU?s | Room: Chinook 1    
Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists
At the completion of this program, the participant will be able to:

    Understand the impact that cultural awareness has in the pharmacist/patient and Technician/patient relationship when serving a patient of different cultural background.

·        Be able to translate simple communicating and prescription directions into basic Spanish to increase Spanish-speaking patient adherence

·        Able to use counseling tools and resources that will assist them with breaching gaps with patients with a communication barrier

This workshop looks at the development of cultural awareness and how it impacts the ability of a pharmacist to counsel a patient with a language barrier. It will start with a brief introduction to the Latino Culture, and build itself to a workshop that provides the audience with tools that will allow them to communicate and translate Rx SIGs into basic Spanish which will increase adherence and improve patient relationships.

Highlights and LOWlights of Hypoglycemia

Faculty: Erin Dobbins, Pharm.D., Joshua J. Neumiller, Pharm.D, CGP, FASCP, Assistant Professor, Wasington State University

ACPE # 130-000-08-061-L01 P&T

Friday November 7, 3-4:15 pm | .150 CEU?s | Room: Chinook 2        

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Define hypoglycemia and discuss strategies for treating hypoglycemic events.

·        Discuss strategies for avoiding hypoglycemic episodes in patients with diabetes mellitus.

·        Utilize clinical scenarios to outline common causes of hypoglycemia, and suggest appropriate interventions and/or strategies for the management of hypoglycemia.

This program will provide an overview of the management of hypoglycemia in patients with diabetes mellitus (DM).  The presenters will briefly review the definition(s) of hypoglycemia, and discuss strategies for avoiding and managing hypoglycemic events in patients with DM due to treatment and/or physical activity.  Clinical case scenarios and pearls will be utilized throughout the presentation to outline common causes of hypoglycemia and management strategies in the ambulatory patient.

Saturday, November 8, 2008

Medicaid Pharmacy Audit Prevention
Presentation         

Faculty: Troy Parks, MPA, Medial Audit Supervisor, Health and Recovery Services Administration, Office of Payment Review and Audit, Teresa Wiggerhaus, Auditor, Health and Recovery Services Administration, Office of Payment Review and Audit        

ACPE # 130-000-08-077-L04 P&T

Saturday November 8, 8-9:15 am | .150 CEU?s | Room: Chinook 1

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Gain greater understanding of HRSA audit process

·        Understand on how to properly bill HRSA

·        Understand review of the internal billing process

Medicaid Pharmacy Audit Prevention will help demystify the audit process and will enable pharmacy owners, managers and employees with the necessary skills to be able to properly bill the Health and Recovery Services Administration (HRSA) for pharmacy services. Information provided will allow pharmacies to review their internal processes to ensure compliance with HRSA billing requirements.

Current Treatment and Future Therapies for Painful Neuropathy

Faculty: Travis E. Sonnett, Pharm.D., Clinical Assistant Professor, Washington State University

ACPE # 130-000-08-062-L01 P

Saturday November 8, 8-9:15 am | .150 CEU?s | Room: Chinook 2

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Identify and outline current available therapies, their strengths and weaknesses, and where they fall in the hierarchy of therapy

·        Discuss the role of a multi-product approach, and the benefits provided by utilizing different mechanisms of therapy

·        Discuss future therapies under investigation and new proposed mechanisms for therapy for neuropathic pain

·        Identify the role of the pharmacist in treatment of neuropathic pain, and the impact the pharmacist may have in multiple setting sin regards to successful outcomes with neuropathic pain patients

Neuropathic pain is an acute or chronic condition that affects patients young and old.  This debilitating condition is difficult to treat effectively, due to a lack of response to available therapies. This program will help identify available therapies and their success or failure characteristics, medications in trial for treatment of painful neuropathy, and the role of the pharmacist in several patient settings.

Health Systems Academy Meeting 

Moderator: Steve Riddle, BS Pharm, BCPS, Lead Pharmacist , Harborview Medical Center Pharmacy Services, Medication Utilization & Quality Improvement, Assistant Clinical Professor, University Of Washington School of Pharmacy, Tony Casanova, Pharm.D., Emergency Department Pharmacist Specialist, St. Joseph Medical Center

ACPE # 130-000-08-071-L04 P&T

Saturday November 8, 8-9:15 am | .150 CEU?s | Room: Chinook 3

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Update members on current activities and goals of the Health Systems Academy.

·        Discuss pharmacists and ?best practice? registry project aimed at addressing professional needs of HSA members.

·        Provide practical information on development and implementation of new pharmacy services for the emergency department (ED). 

The Health-systems Academy general meeting will provide a forum for exchange of information regarding issues pertinent to health-systems practice including clinical, professional and legislative topics. The meeting will also focus on the role of the Academy in meeting the needs of health-systems pharmacy practitioners such as professional development and networking opportunities.  Pharmacists involved in the development and maintenance of a pharmacy services for the emergency department will present key data and practical guidance for establishing such services.

Emerging Pharmacist Services Models: The CCNC Network Pharmacist Program       

Faculty: Troy Trygstad, Pharm.D., MBA, Ph.D., Director of the Network Pharmacy Program, Community Care of North Carolina          

ACPE # 130-000-08-073-L04 P&T

Saturday November 8, 9:30-10:45 am | .150 CEU?s | Room: Chinook 1

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Identify emerging pharmacist service models

·        Understand the importance of constructing a business model with all stakeholders

·        Understand the importance of interpersonal relationships in multi-disciplinary collaboration and pharmacist extenders

This session will outline the development of a network of pharmacists in North Carolina that was put together for the purpose of supporting the development of the medical home, along with nurse case managers, social workers and health educators.

Improving Outcomes in Venous Thromboembolism Using Performance Measures        

Faculty: William E. Dager, Pharm.D., FCSHP, Pharmacist Specialist, UC Davis Medical Center; Clinical Professor of Pharmacy, University of California, San Francisco; Clinical Professor of Medicine, University of California, Davis

ACPE # 204-000-08-443-L03 P | statement of credits are issued by ASHP

Saturday November 8, 9:30-10:30 am | .10 CEU?s | Room: Chinook 2

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Describe the rationale for national performance measures in improving the quality of care for a medical or surgical patient receiving anticoagulant therapy.

·        Identify a national organization and initiative to improve the quality of anticoagulant use for the prevention or treatment of venous thromboembolism (VTE).

·        Define the role of pharmacists and other health care providers in the implementation of performance measures to improve the quality of anticoagulant therapy.

·        Identify a strategy for meeting the Joint Commission NPSG for reducing harm from anticoagulants.

Deep vein thrombosis (DVT) strikes approximately 2 million Americans each year.  A potential deadly consequence of DVT is pulmonary embolism (PE). The clinical aftermath spans a wide spectrum from inconsequential to fatal. Annual hospitalization and follow-up treatment costs for DVT and PE, or venous thromboembolism (VTE), carry a burden of $1.5 billion to the United States healthcare system.

Anticoagulant therapy plays a critical role in VTE treatment and prevention.

Safe and effective anticoagulant therapy has been the focus of national quality initiatives that use evidence-based performance measures to evaluate and improve the quality of patient care.  Reducing the likelihood of patient harm associated with the use of anticoagulant therapy has been established as a 2008 National Patient Safety Goal (NPSG) by the Joint Commission.  The Joint Commission and the National Quality Forum have developed national consensus standards for the prevention and care of VTE. A reduction in surgical complications by 25% before 2010 is the goal of the Surgical Care Improvement Project (SCIP), a quality improvement initiative of the Centers for Medicare and Medicaid Services.  The appropriate use of VTE prophylaxis is among the aspects of care targeted in the SCIP program. The use of these performance measures on a nationwide basis allows quality comparisons among institutions.

Health care providers need education and tools to evaluate and improve the quality of anticoagulant use in their institutions.  This presentation will focus on quality initiatives and provide strategies for using performance measures to assess and improve quality of care and meet national standards and goals in the clinical practice setting.  Participants will be engaged in an active learning process through the use of a patient case to illustrate key concepts covered in the program.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1.0 hour (0.1 CEU) of continuing education credit (activity number 204-000-08-443-L03P).  Attendees must complete a Continuing Pharmacy Education Request online and may print their official ASHP CE statements at http://ce.ashp.org.

Planned and conducted by ASHP Advantage. Supported by an educational grant from sanofi-aventis U.S.

Long Term Care Academy and ASCP Chapter Meeting

Faculty: Steve Boulanger, R.Ph., FASCP, Owner, Mercury Pharmacy

ACPE #  130-000-08-078-L04 P&T

Saturday November 8, 9:30-10:45 am| .150 CEU?s | Room: Chinook 3

Target Audience: Long Term Care Pharmacist, Technicians

At the completion of this program, the participant will be able to:

·        Discuss current trends in pharmacy practice.

·        Propose and discuss specific issues and needs pertaining to your practice setting.

·        Update on state and federal legislative/regulatory issues pertaining to pharmacy.

·        Discuss strategies to reinforce more patient-centric mission for our profession.

This CE program is designed to target the needs of pharmacists, technicians and interns working in specific pharmacy settings. We will discuss the current issues affecting pharmacy practice in general throughout Washington State as well as how these issues relate to this practice setting. We will discuss Medication Therapy Management implementation and reimbursement models including NPI, and billing codes, pharmacists/pharmacy professional responsibility rules, potential legislation, and the movement toward a more patient-centric mission for our profession. The second part of the meeting will be the ASCP Chapter meeting.  Participants will be encouraged to contribute their thoughts in this active program.

Trends in Health Care Technology: Impact on Patients and the Pharmacist        

Faculty: Troy Trygstad, Pharm.D., MBA, Ph.D., Director of the Network Pharmacy Program, Community Care of North Carolina, Dale Christensen, Ph.D., R.Ph., Consultant to the health insurance industry focusing on prescription and pharmaceutical care delivery models, Emeritus Professor at the University of North Carolina School of Pharmacy

ACPE # 130-000-08-074-L04 P&T

Saturday November 8, 11-12:15 pm | .150 CEU?s | Room: Chinook 1

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Identify emerging trends driving patients to more self care

·        Understand how technology is making PHI available to consumers

·        Understand how patient health information is being used to promote and assist in patient self care

·        Understand how health care systems are using PHI to influence patient health behavior

·        Determine the role of the pharmacy staff in today?s health care world and how it is influenced by emerging technologies

This session will identify emerging technologies that are evolving in response to consumer-directed health care and disease self-management strategies.  The role and the setting of the pharmacist in these strategies has yet to be fully defined and are explored in this session.

Pharmacogenetics and Personalized Medicine, Existing and Emerging Applications to Clinical Practice

Faculty: Howard Coleman, BS, BA     

ACPE # 130-000-08-070-L04 P

Saturday November 8, 11-12:15 pm | .150 CEU?s | Room: Chinook 2

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Describe the latest studies validating specific drug-gene applications

·        Determine when ordering a pharmacogenetic DNA test would be appropriate

·        Understand how to interpret Pharmacogenetic DNA test results

·        Use interpretive software to apply test results to a specific patient medication regimen

The talk will review the basic premises of pharmacogenetics and describe the latest studies validating specific drug-gene applications, such as the use of DNA testing to determine warfarin dosing and tamoxifen effectiveness. Available software tools for interpreting pharmacogenetic test results within the framework of relevant clinical factors and overall medication regimens will be demonstrated. I?ll also discuss the current climate with respect to acceptance, reimbursement and regulation of these tests.

Pharmacy Owners Academy Meeting

Faculty: Janet Kusler, R.Ph., Owner, Kusler's Pharmacy

ACPE # 130-000-08-079-L04 P&T

Saturday November 8, 11-12:15 pm | .150 CEU?s | Room: Chinook 3

Target Audience: Pharmacy Owners

At the completion of this program, the participant will be able to:

·        Discuss current issues pertaining to pharmacy ownership.

·        Propose and discuss specific ideas and needs pertaining to pharmacy ownership.

·        Update on state and federal legislative/regulatory issues pertaining to community pharmacy.

·        Discuss strategies to increase the number of patient-centric initiatives in community pharmacy.

This CE program is designed to target the needs of pharmacists, technicians and interns who are interested in pharmacy ownership, as well as current pharmacy owners. We will discuss the current legislative issues affecting pharmacy practice in general throughout Washington State and nationally.  Participants will be encouraged to contribute their thoughts in this active program.

Technician Academy Meeting (Working Lunch)                

Faculty: Sandi Tschritter, CPhT, Charlene Daniel, Technician

ACPE # 130-000-08-075-L04 T

Saturday November 8, 1:30-3:15 pm | .100 CEU?s | Room: Chinook 3

Target Audience: Technicians

At the completion of this program, the participant will be able to:

·         Discuss current trends in pharmacy practice.

·         Propose and discuss specific issues and needs pertaining to your practice setting.

·         Update on state and federal legislative/regulatory issues pertaining to pharmacy.

·         Discuss strategies to reinforce more patient-centric mission for our profession

This CE program is designed to target the needs of pharmacists, technicians and interns working in specific pharmacy settings. We will discuss the current issues affecting pharmacy practice in general throughout Washington State as well as how these issues relate to this practice setting. We will discuss Medication Therapy Management implementation and reimbursement models including NPI, and billing codes, pharmacists/pharmacy professional responsibility rules, potential legislation, and the movement toward a more patient-centric mission for our profession. Participants will be encouraged to contribute their thoughts in this active program.

Current Issues in Pharmacy Practice: General Membership Meeting                 

Faculty:

ACPE # 130-000-08-080-L04 P&T

Saturday November 8, 1:30-3:15 pm | .200 CEU?s | Room: Chinook 1, 2 & 3

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Students

At the completion of this program, the participant will be able to:

·        Discuss state and federal legislative/regulatory issues pertaining to pharmacy

·        Discuss strategies to transition to an equitable reimbursement model

·        Discuss current positive and negative trends in pharmacy practice

·        Discuss strategies to educate legislators, other healthcare providers and the general public about the value of pharmacy

Federal Controlled Substances Guidelines and Legal Remedies  

Faculty: Ruth Carter, Group Supervisor, DEA, Ron Friedman, Asst. U.S. Attorney, Criminal Enterprise Unit,

United States Attorneys Office

ACPE # 130-000-08-069-L03 P&T

Saturday November 8, 3:30-4:45 pm | .150 CEU?s | Room: Chinook 1

Target Audience: Community Ambulatory, Health Systems, Long Term Care, Technicians, Student Pharmacists

At the completion of this program, the participant will be able to:

·        Summarize the federal controlled substances regulations and laws.

·        Discuss new federal regulations including Schedule 2 prescriptions

·        Understand Take Back Program - federal regulations.

·        Understand Pharmacy Robberies and Burglaries

·        Discuss the federal law as it relates to pharmaceutical controlled substances.

·        Summarize criminal prosecution and adverse licensing consequences.

Health-Systems Academy Clinical Pearls
Presentation
Moderator: Steve Riddle, BS Pharm, BCPS, Lead Pharmacist , Harborview Medical Center Pharmacy Services, Medication Utilization & Quality Improvement, Assistant Clinical Professor, University Of Washington School of Pharmacy

ACPE # 130-000-08-072-L04-P

Saturday November 8, 3:30-4:45 pm | .150 CEU?s | Room: Chinook 2

Target Audience: Health Systems Pharmacists

At the completion of this program, the participant will be able to:

·        Increase knowledge over a wide-range of clinical topics.

·        Improve appropriateness, safety and/or cost-effectiveness of drug therapy for patients based on practical, sound pharmacotherapy ?pearls?.

·        Discuss novel clinical issues in pharmacy practice that fall outside standard information sources.

This program will consist of a collection of short presentations (10 minutes each) by pharmacists. The goal of each pearl presentation is to convey one idea, concept, or fact, which may be useful in day-to-day practice. The information may focus on a topic that is not widely known, understood, published, or taught or provide a concise summary of complex clinical information in a very practical manner. This program serves as a fun and valuable method for improving the pharmacist?s clinical knowledge base on a wide spectrum of topics.

Community/Ambulatory Practice Academy Meeting

Faculty: Steve Singer, R.Ph., Pharmacist, Bellegrove Pharmacy

ACPE # 130-000-08-081-L04 P&T

Friday November 8, 3:30-4:45 pm | .150 CEU?s | Room: Chinook 3

Target Audience: Community Ambulatory, Technicians, Students

Upon completion of this program, the participants will be able to:

·        Discuss current trends in pharmacy practice.

·        Propose and discuss specific issues and needs pertaining to your practice setting.